2023 PCE Oncology Spring Conferences – Hematologic Malignancies

PCE, the national leader in continuing education for NPs and PAs, presents the 2023 PCE Oncology Spring Conferences – Hematologic Malignancies. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Review the latest evidence-based strategies for contemporary care of your patients with hematologic malignancies with downloadable slides from CCO and PCE. 

Share

Program Content

Activities

Managing CLL/SLL and MCL
Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2023

Managing CLL/SLL and MCL with BTKis
Current and Novel Approaches to the Management of Patients With CLL/SLL and MCL Using BTK Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 25, 2023

BTKi and BCL-2i in MCL and CLL/SLL
Mastering the Use of BTK- and BCL2- Inhibitors in the Management of MCL and CLL/SLL
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2023

Expires: June 26, 2024

Activities

CAR T Nursing Practice
Navigating the New Advances in CAR T-Cell Therapy: Clinical Applications for Nursing Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Activities

Myelofibrosis Care
A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review and Case Challenges Illustrating Current Therapeutic Standards
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Faculty

cover img faculity

Kathryn Ciccolini, DNP, AGACNP-BC, OCN

Clinical Program Manager
Nurse Practitioner
Bone Marrow Transplant and Cellular Therapy Service
Mount Sinai Hospital
New York, New York

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Linda Ramsdell, MSN, FNP-BC, OCN

Assistant Program Director 
Immune Effector Cellular Therapy
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Bristol-Myers Squibb; CTI BioPharma Corp; GSK; and Incyte Corporation.

AstraZeneca

Bristol Myers Squibb

CTI BioPharma Corp., a Sobi Company

GSK

Incyte Corporation